1. Home
  2. FTEL vs ERNA Comparison

FTEL vs ERNA Comparison

Compare FTEL & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$0.88

Market Cap

9.1M

Sector

N/A

ML Signal

HOLD

Logo Eterna Therapeutics Inc.

ERNA

Eterna Therapeutics Inc.

HOLD

Current Price

$1.26

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEL
ERNA
Founded
2007
2018
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
10.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
FTEL
ERNA
Price
$0.88
$1.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.1M
56.8K
Earning Date
11-17-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,200,138.00
$1,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.42
N/A
52 Week Low
$0.62
$1.09
52 Week High
$792.00
$14.40

Technical Indicators

Market Signals
Indicator
FTEL
ERNA
Relative Strength Index (RSI) 36.31 45.90
Support Level $0.80 $1.10
Resistance Level $2.00 $1.32
Average True Range (ATR) 0.21 0.10
MACD 0.11 -0.01
Stochastic Oscillator 17.31 50.00

Price Performance

Historical Comparison
FTEL
ERNA

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.

About ERNA Eterna Therapeutics Inc.

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Share on Social Networks: